PerryWGrigsbyMD

Radiation Oncology • Saint Louis, MO

Gynecologic Cancer

Professor, Radiation Oncology, Washington University School of Medicine

Join to view full profile

Dr. Grigsby is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Grigsby's full profile

Already have an account?

Office
1 Barnes Jewish Hospital Plz
Dept
Saint Louis, MO 63110
Phone+1 314-362-7000

Fax+1 314-747-4189

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Radiation Oncology, 1982 - 1986
University of Kentucky College of MedicineClass of 1982

Certifications & Licensure

MO State Medical License 1983 - 2026
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013

Clinical Trials

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer Start of enrollment: 2000 Jul 01
Completed
Phase 1
Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients Start of enrollment: 2006 Apr 01
Completed
Phase 1
Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients Start of enrollment: 2006 Feb 01
Completed
Phase 1
A Phase II Study of Extended Field IMRT External Beam Irradiation and Intracavitary Brachytherapy Start of enrollment: 2003 May 01
Terminated
Phase 2
A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma Start of enrollment: 2009 Jun 04
Active, not recruiting
Phase 2
Fludeoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Cervical Heterogenity Imaging Study Start of enrollment: 2008 Aug 01
Completed
Not Applicable
Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer Start of enrollment: 2009 Aug 01
Terminated
Phase 2
Ultrasound and Photoacoustic Imaging for Cervical Cancer Start of enrollment: 2018 Feb 15
Terminated
Not Applicable
Join now to see all

Publications & Presentations

PubMed

1 citations
Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation.
Victoria Shi, Surbhi Grover, Yi Huang, Premal H Thaker, Lindsay M Kuroki
International Journal of Gynecological Cancer. 2024-06-03
13 citations
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Ca...
William A Peters 3rd, P Y Liu, Rolland J Barrett 2nd, Richard J Stock, Bradley J Monk
Journal of Clinical Oncology. 2023-10-10
11 citations
SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production.
Liyun Chen, Victoria Shi, Songyan Wang, Lulu Sun, Rebecca Freeman
The Journal of Clinical Investigation. 2023-08-01

Press Mentions

UIC Announces Students, Alumni Offered Fulbright Awards for 2021-2022August 11th, 2021
ESGO/ESTRO/ESP Guidelines for the Management of Patients with Endometrial CarcinomaFebruary 19th, 2021

Grant Support

Intra-Tumoral Metabolic Heterogeneity Of Cervical CancerNational Cancer Institute2009–2011